الانتقال الى المحتويات

علم الدم

فقر الدم اللاتنسجي

Eltrombopag added to immunosuppression in severe aplastic anemia. (يفتح نافذة جديدة)

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

Source‎: N Engl J Med 2022;386(1):11-23.

مفهرسة‎: PubMed 34986284

DOI‎: 10.1056/NEJMoa2109965

https://pubmed.ncbi.nlm.nih.gov/34986284/ (يفتح نافذة جديدة)

Eltrombopag added to standard immunosuppression for aplastic anemia. (يفتح نافذة جديدة)

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

Source‎: N Engl J Med 2017;376(16):1540-50.

مفهرسة‎: PubMed 28423296

DOI‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296 (يفتح نافذة جديدة)